BR0303080A - Seleção de marcadores - Google Patents
Seleção de marcadoresInfo
- Publication number
- BR0303080A BR0303080A BR0303080-6A BR0303080A BR0303080A BR 0303080 A BR0303080 A BR 0303080A BR 0303080 A BR0303080 A BR 0303080A BR 0303080 A BR0303080 A BR 0303080A
- Authority
- BR
- Brazil
- Prior art keywords
- parameters
- measure
- diagnostic
- selecting
- relationship
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108700026220 vif Genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Complex Calculations (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36879002P | 2002-03-29 | 2002-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0303080A true BR0303080A (pt) | 2004-02-17 |
Family
ID=27805329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0303080-6A BR0303080A (pt) | 2002-03-29 | 2003-03-28 | Seleção de marcadores |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20030194734A1 (enExample) |
| EP (1) | EP1349104A3 (enExample) |
| JP (1) | JP2004163388A (enExample) |
| KR (1) | KR20030078803A (enExample) |
| CN (1) | CN1495272A (enExample) |
| AR (1) | AR039212A1 (enExample) |
| AU (1) | AU2003203529A1 (enExample) |
| BR (1) | BR0303080A (enExample) |
| CA (1) | CA2422309A1 (enExample) |
| MX (1) | MXPA03002865A (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1361433A3 (en) * | 2002-04-09 | 2005-02-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Method for estimating therapeutic efficacy of tumor necrosis factor (TNF) |
| US20040191782A1 (en) * | 2003-03-31 | 2004-09-30 | Yixin Wang | Colorectal cancer prognostics |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| CA2575986A1 (en) * | 2004-08-02 | 2006-02-09 | Banyu Pharmaceutical Co., Ltd. | Method of assuming drug sensitivity to cdk4 inhibitor |
| US20060252057A1 (en) * | 2004-11-30 | 2006-11-09 | Mitch Raponi | Lung cancer prognostics |
| US7871774B2 (en) | 2005-01-31 | 2011-01-18 | Digital Genomics Inc. | Markers for the diagnosis of lung cancer |
| KR100690250B1 (ko) * | 2005-01-31 | 2007-03-12 | 디지탈 지노믹스(주) | 폐암 진단용 마커 |
| US20070037186A1 (en) | 2005-05-20 | 2007-02-15 | Yuqiu Jiang | Thyroid fine needle aspiration molecular assay |
| IL177006A0 (en) | 2005-08-02 | 2006-12-10 | Veridex Llc | Predicting bone relapse of breast cancer |
| US20070130694A1 (en) * | 2005-12-12 | 2007-06-14 | Michaels Emily W | Textile surface modification composition |
| US20070207467A1 (en) | 2006-03-01 | 2007-09-06 | Ming Xu | Detection of lymph node metastasis from gastric carcinoma |
| BRPI0708534A2 (pt) * | 2006-03-03 | 2011-05-31 | Veridex Llc | ensaio molecular para prognosticar a recorrência de cáncer do cólon dukes b |
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| US20080306881A1 (en) * | 2006-12-22 | 2008-12-11 | X-Shares Advisors Llc | Portfolio selection for custom indices of public securities based on state of domicile of issuing company |
| US20080206777A1 (en) | 2007-02-27 | 2008-08-28 | Nuclea Biomarkers, Llc | Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors |
| EP2240609A4 (en) * | 2008-01-22 | 2011-08-03 | Veridex Llc | MOLECULAR CLASSIFICATION OF COLONCARCINOMA STADIAS II AND III AND FORECAST |
| US20110059464A1 (en) | 2008-04-08 | 2011-03-10 | Muraca Patrick J | Biomarker Panel For Prediction Of Recurrent Colorectal Cancer |
| CA2725978A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| EP2730662A1 (en) | 2008-11-12 | 2014-05-14 | Caris Life Sciences Luxembourg Holdings | Methods and systems of using exosomes for determining phenotypes |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| CA2753916C (en) | 2009-04-29 | 2020-08-25 | Genomedx Biosciences Inc. | Systems and methods for expression-based classification of thyroid tissue |
| US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| US9128101B2 (en) | 2010-03-01 | 2015-09-08 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| BR112012025593A2 (pt) | 2010-04-06 | 2019-06-25 | Caris Life Sciences Luxembourg Holdings | biomarcadores em circulação para doença |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| AU2013302365B2 (en) | 2012-08-16 | 2019-03-21 | Mayo Foundation For Medical Education And Research | Cancer diagnostics using biomarkers |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| WO2016073768A1 (en) | 2014-11-05 | 2016-05-12 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| CA3050984A1 (en) | 2017-01-20 | 2018-07-26 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| CA3055925A1 (en) | 2017-03-09 | 2018-09-13 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1000347B (el) * | 1988-12-21 | 1992-06-25 | Ortho Diagnostic Systems Inc | Μεθοδος παραγωγης νουκλεοτιδικων ανιχνευτων χρησιμοποιωντας ενα συμπληρωμα γεφυρωσεως. |
| US6350576B1 (en) * | 1994-12-20 | 2002-02-26 | Cold Spring Harbor Laboratory | Cancer detection probes |
| US5972614A (en) * | 1995-12-06 | 1999-10-26 | Genaissance Pharmaceuticals | Genome anthologies for harvesting gene variants |
| US6275814B1 (en) * | 1996-11-27 | 2001-08-14 | Investment Strategies Network | Investment portfolio selection system and method |
| US6003018A (en) * | 1998-03-27 | 1999-12-14 | Michaud Partners Llp | Portfolio optimization by means of resampled efficient frontiers |
| US6882990B1 (en) * | 1999-05-01 | 2005-04-19 | Biowulf Technologies, Llc | Methods of identifying biological patterns using multiple data sets |
| US6401043B1 (en) * | 1999-04-26 | 2002-06-04 | Variagenics, Inc. | Variance scanning method for identifying gene sequence variances |
| US6175824B1 (en) * | 1999-07-14 | 2001-01-16 | Chi Research, Inc. | Method and apparatus for choosing a stock portfolio, based on patent indicators |
| EP1196027A4 (en) * | 1999-07-15 | 2004-12-22 | Res Dev Foundation | CORTICOTROPIN RELEASE FACTOR-2 RECEPTOR 2 MOUSE AND USES THEREOF |
-
2003
- 2003-03-21 US US10/394,087 patent/US20030194734A1/en not_active Abandoned
- 2003-03-28 CA CA002422309A patent/CA2422309A1/en not_active Abandoned
- 2003-03-28 AU AU2003203529A patent/AU2003203529A1/en not_active Abandoned
- 2003-03-28 BR BR0303080-6A patent/BR0303080A/pt not_active IP Right Cessation
- 2003-03-29 CN CNA031312047A patent/CN1495272A/zh active Pending
- 2003-03-29 KR KR10-2003-0019839A patent/KR20030078803A/ko not_active Withdrawn
- 2003-03-31 JP JP2003095679A patent/JP2004163388A/ja active Pending
- 2003-03-31 MX MXPA03002865A patent/MXPA03002865A/es unknown
- 2003-03-31 EP EP03252027A patent/EP1349104A3/en not_active Withdrawn
- 2003-04-01 AR ARP030101133A patent/AR039212A1/es not_active Application Discontinuation
-
2009
- 2009-07-01 US US12/496,399 patent/US20100009371A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030078803A (ko) | 2003-10-08 |
| US20100009371A1 (en) | 2010-01-14 |
| AU2003203529A1 (en) | 2003-10-23 |
| US20030194734A1 (en) | 2003-10-16 |
| EP1349104A3 (en) | 2004-01-02 |
| AR039212A1 (es) | 2005-02-09 |
| EP1349104A2 (en) | 2003-10-01 |
| JP2004163388A (ja) | 2004-06-10 |
| CA2422309A1 (en) | 2003-09-29 |
| MXPA03002865A (es) | 2004-08-11 |
| CN1495272A (zh) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0303080A (pt) | Seleção de marcadores | |
| BRPI0411743A (pt) | método e composições para tratar doenças relacionadas a amilóides | |
| BRPI0407734A (pt) | derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo | |
| BR0212809A (pt) | Inibidores de anticorpos de gdf-8 e usos dos mesmos | |
| EP1687283A4 (en) | FOR THE DETERMINATION OF FK506 PROCEDURE AND COMPOSITION | |
| CA2417500A1 (en) | Erbb-2 selective small molecule kinase inhibitors | |
| BRPI0407397A (pt) | Evento de algodão mon 88913 e composições e métodos para sua detecção | |
| BR0214805A (pt) | Lama viscosa de alta perda de fluido solúvel em ácido para circulação perdida | |
| BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
| BR0207332A (pt) | Composição de fluido de fraturamento hidráulico, e, processo para gerar fissuras em uma formação subterrânea | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| ATE457780T1 (de) | Ein dikationischer diazofarbstoff enthaltende farbstoffzusammensetzung zum färben von keratinischen fasern | |
| BRPI0415760A (pt) | derivados de benzimidazolila | |
| WO2004007743A3 (en) | Use of cpg nucleic acids in prion-disease | |
| AR045016A1 (es) | Derivados de 5-carbamimidoi-2-metilsulfaniltiofen-3-sulfonil como inhibidores conjugados de la cascada de complemento y su uso en el tratamiento de enfermedades. | |
| BRPI0416156A (pt) | uso de tienopirimidinas | |
| BRPI0801078A2 (pt) | processo para relaxar ou alisar os cabelos | |
| BRPI0410149A (pt) | métodos para determinar caracterìsticas de formação e para determinar compactação de formação | |
| BRPI0417732A (pt) | aplicação de gene amilóide a sérico no diagnóstico e tratamento do glaucoma e identificação de agentes antiglaucoma | |
| BR0308055A (pt) | Processo para a preparação de compostos de azo catiÈnicos | |
| CA2366514A1 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
| BRPI0407031A (pt) | Composições e métodos para tratamento de câncer empregando igsf9 e liv-1 | |
| BR0011339A (pt) | Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase | |
| WO2005012482A3 (en) | Assay for identification of bioactive compounds that interact with heat shock protein 90 | |
| EP1572225A4 (en) | THROMBOSPONDIN FRAGMENTS AND THEIR USE IN CLINICAL CANCER TESTS AND THE PRODUCTION OF ANTIBODIES AND OTHER BINDING AGENTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2042 DE 23/02/2010. |